Medullary thyroid cancer classification: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(One intermediate revision by the same user not shown)
Line 3: Line 3:
{{CMG}}; {{AE}} {{Ammu}}
{{CMG}}; {{AE}} {{Ammu}}
==Overview==
==Overview==
Medullary thyroid cancer may be [[classification|classified]] according to the mode of occurrence into 2 groups: [[sporadic]] medullary thyroid cancer and inherited medullary thyroid cancer.
Medullary thyroid cancer may be [[classification|classified]] according to the mode of occurrence into 2 groups: sporadic medullary thyroid cancer and [[inherited]] medullary thyroid cancer.
==Classification==
==Classification==
* Medullary thyroid cancer may be [[classification|classified]] according to the mode of occurrence into 2 groups: sporadic medullary thyroid cancer and inherited medullary thyroid cancer.
* Medullary thyroid cancer may be [[classification|classified]] according to the mode of occurrence into 2 groups: sporadic medullary thyroid cancer and [[inherited]] medullary thyroid cancer.
* Sporadic medullary thyroid cancer<ref>Thyroid Cancer  Cancer.gov
* Sporadic medullary thyroid cancer<ref>Thyroid Cancer  Cancer.gov
(2015). http://www.cancer.gov/types/thyroid/hp/thyroid-treatment-pdq#link/stoc_h2_2- Accessed on October, 29 2015</ref><ref name="RaueFrank-Raue2015">{{cite journal|last1=Raue|first1=Friedhelm|last2=Frank-Raue|first2=Karin|title=Epidemiology and Clinical Presentation of Medullary Thyroid Carcinoma|volume=204|year=2015|pages=61–90|issn=0080-0015|doi=10.1007/978-3-319-22542-5_3}}</ref>
(2015). http://www.cancer.gov/types/thyroid/hp/thyroid-treatment-pdq#link/stoc_h2_2- Accessed on October, 29 2015</ref><ref name="RaueFrank-Raue2015">{{cite journal|last1=Raue|first1=Friedhelm|last2=Frank-Raue|first2=Karin|title=Epidemiology and Clinical Presentation of Medullary Thyroid Carcinoma|volume=204|year=2015|pages=61–90|issn=0080-0015|doi=10.1007/978-3-319-22542-5_3}}</ref>
:* Sporadic medullary thyroid cancer (75% of the cases)
:* Sporadic medullary thyroid cancer (75% of the cases)
:* Inherited medullary thyroid cancer (25% of the cases)
:* Inherited medullary thyroid cancer (25% of the cases)
:** MEN2A (23%)
:**[[Multiple endocrine neoplasia type 2A|MEN2A]] (23%)
:** MEN2B (2%)
:**[[Multiple endocrine neoplasia type 2B|MEN2B]] (2%)
:** Familial medullary thyroid cancer (FMTC)(rare)
:**[[Familial]] medullary thyroid cancer (FMTC)(rare)
* Medullary thyroid cancer may be [[classification|classified]] according to [[histologic]] variants into:<ref>{{cite book | last = DeLellis | first = Ronald | title = Pathology and genetics of tumours of endocrine organs | publisher = IARC Press | location = Lyon | year = 2004 | isbn = 92-832-2416-7 }}</ref>
* Medullary thyroid cancer may be [[classification|classified]] according to [[histologic]] variants into:<ref>{{cite book | last = DeLellis | first = Ronald | title = Pathology and genetics of tumours of endocrine organs | publisher = IARC Press | location = Lyon | year = 2004 | isbn = 92-832-2416-7 }}</ref>
** Papillary or pseudopapillary due to the presence of papillary structures or artifactual structures resembling papillae.
** Papillary or pseudopapillary due to the presence of papillary structures or artifactual structures resembling papillae.

Latest revision as of 15:24, 29 August 2019

Medullary thyroid cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Medullary thyroid cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

CT

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Medullary thyroid cancer classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Medullary thyroid cancer classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Medullary thyroid cancer classification

CDC on Medullary thyroid cancer classification

Medullary thyroid cancer classification in the news

Blogs on Medullary thyroid cancer classification

Directions to Hospitals Treating Medullary thyroid cancer

Risk calculators and risk factors for Medullary thyroid cancer classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

Medullary thyroid cancer may be classified according to the mode of occurrence into 2 groups: sporadic medullary thyroid cancer and inherited medullary thyroid cancer.

Classification

  • Medullary thyroid cancer may be classified according to the mode of occurrence into 2 groups: sporadic medullary thyroid cancer and inherited medullary thyroid cancer.
  • Sporadic medullary thyroid cancer[1][2]
  • Sporadic medullary thyroid cancer (75% of the cases)
  • Inherited medullary thyroid cancer (25% of the cases)
  • Medullary thyroid cancer may be classified according to histologic variants into:[3]
    • Papillary or pseudopapillary due to the presence of papillary structures or artifactual structures resembling papillae.
    • Glandular
    • Giant cells
    • Spindle cell
    • Small cell and Neuroblastoma-like
    • Paraganglioma-like
    • Onchocytic cell
    • Clear cell
    • Angiosarcoma-like
    • Squamous cell
    • Melanin-producing
    • Amphicrine

Reference

  1. Thyroid Cancer Cancer.gov (2015). http://www.cancer.gov/types/thyroid/hp/thyroid-treatment-pdq#link/stoc_h2_2- Accessed on October, 29 2015
  2. Raue, Friedhelm; Frank-Raue, Karin (2015). "Epidemiology and Clinical Presentation of Medullary Thyroid Carcinoma". 204: 61–90. doi:10.1007/978-3-319-22542-5_3. ISSN 0080-0015.
  3. DeLellis, Ronald (2004). Pathology and genetics of tumours of endocrine organs. Lyon: IARC Press. ISBN 92-832-2416-7.